Rubbert-Roth, Andrea
Furst, Daniel E.
Fiore, Stefano
Praestgaard, Amy
Bykerk, Vivian
Bingham, Clifton O.
Charles-Schoeman, Christina
Burmester, Gerd
Article History
Received: 8 March 2022
Accepted: 7 August 2022
First Online: 25 August 2022
Declarations
:
: The protocols used in the TARGET, MOBILITY, and MONARCH were approved by the appropriate ethics committees/institutional review boards, and each patient provided written informed consent before participating in the study. The studies were conducted in compliance with institutional review board regulations, the International Conference on Harmonization Guidelines for Good Clinical Practice, and the Declaration of Helsinki.
: A. RR. has received honoraria for lectures and consultation from Sanofi, Abbvie, Lilly, Gilead, Roche, BMS, Boehringer, Novartis, Janssen, UCB, and Amgen.D. F. has received grants and/or consulting fees from Actelion, Amgen, Bristol-Myers Squibb, Corbus, Galapagos, GlaxoSmithKline, Horizon, Kadmon, NIH, Novartis, Pfizer, Roche/Genentech, Talaris, and Sanofi Genzyme/Regeneron.S. F. and A. P. are employees of Sanofi and may hold stock and/or stock options in the company.V. B. has received consulting fees from Amgen; Bristol-Myers Squibb; Gilead; Pfizer; Regeneron Pharmaceuticals, Inc.; Sanofi Genzyme; and UCB, and her host institution has received research grants from Amgen, the Cedar Hill Foundation, and National Institutes of Health.C. B. has received grants and/or consulting fees from AbbVie, Bristol-Myers Squibb, Janssen, Lilly, Pfizer, and Sanofi Genzyme/Regeneron.C. CS. has received grants and/or consulting fees from AbbVie, Amgen, Bristol-Myers Squibb, Gilead, Octopharma, Pfizer, and Sanofi Genzyme/Regeneron.G.B. has received grant/research support, consulting fees, and/or speaker fees/honoraria from AbbVie, Lilly, Merck Sharp & Dohme, Pfizer, Roche, Sanofi Genzyme, and UCB.